Singapore
It plans to secure more regulatory approvals for its AI pathology platform.
Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.
![[Left-Right] Travis Seet, CFO, and Dr Chin Pak Lin, CEO, Asian Healthcare Specialists; Lim Wai Mun, CEO and founder, and Edwin Basuki, CFO, Doctor Anywhere Credit: Doctor Anywhere](/sites/mhn/files/styles/230x130/public/2025-07/Photo_Doctor%2520Anywhere%2520acquires%2520Singapore-listed%2520Asian%2520Healthcare%2520Specialists%252C%2520secures%2520additional%2520US%252438.8%2520million%2520funding.jpg?itok=BMyCZa_X)
The company seeks to meet the rising demand for specialised care across Southeast Asia.
However, these tools are not yet able to provide personalised advice.
This follows its earlier approvals from the US, Europe, Japan and Taiwan.
Also, a Thai language speech recognition AI has been deployed for screening depression in Thailand.
It connects with over 40 brands of wireless medical devices and integrates with popular EMR platforms.
It features a 24-session guided game that is paired with an EEG headband to track brainwaves.
It plans to hire more talent and pursue M&A opportunities to scale.
Its technology helps eliminate manual steps in reporting and interpretation of ultrasound images of breast and thyroid.